What's Going On With Hims & Hers Health Shares Monday? - Hims & Hers Health ( NYSE:HIMS )
Shares of Hims & Hers Health Inc ( NYSE:HIMS ) are trading marginally lower Monday morning, as competitive news overshadows bullish announcements from the company. Here's what investors need to know. HIMS is facing resistance from sellers. Get the market research here.
Hims & Hers Introduces Labs With Annual Plans For Comprehensive Testing - Hims & Hers Health ( NYSE:HIMS )
Hims & Hers Health, Inc. ( NYSE:HIMS ) announced the launch of Labs, a new way for customers to understand their overall health and identify ways to improve and maintain it. Labs measures key markers over time and provides doctor-developed action plans.
Family Alleges Hims & Hers Health, Inc.'s Rush Into Mental Healthcare Violated Washington Law and Resulted in Son's Death
SEATTLE, Nov. 14, 2025 ( GLOBE NEWSWIRE ) -- This week, the parents of Luke Tyler, the Washington State University ( WSU ) freshman who was found dead in his dorm room on January 22, 2023, filed a wrongful death lawsuit in the King County Superior Court against Hims & Hers Health, Inc. ( Hims ) ...
2 Strong Healthcare Stock Picks for Growth Investors
If you're a growth-oriented stock buyer, there are plenty of options in the healthcare space.
2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors
Healthcare stocks have plenty to offer new investors.
Hims & Hers Scales Technology-Enabled, Vertically Integrated Care
HIMS deepens its technology-enabled care model with new offerings in GLP-1 weight loss, hormone health, and custom treatments.
Should Invesco S&P MidCap 400 Pure Growth ETF ( RFG ) Be on Your Investing Radar?
Style Box ETF report for ...
Hims & Hers Revenue Continues to Surge. Is It Time to Buy the Stock?
The company continues to have a strong growth outlook ahead.
Hims & Hers Expands AI-Driven Personalized and Subscription-Based Care
HIMS expands its AI-powered, subscription-based care model globally, backed by $870 million in fresh funding for growth.
Is Most-Watched Stock Hims & Hers Health, Inc. ( HIMS ) Worth Betting on Now?
Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hims & Hers Stock Slips Post Y/Y Q3 Earnings Decline, Margins Contract
HIMS reports lower third-quarter 2025 earnings even as revenue and subscriber growth remain strong across its channels.
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell ( OMCL Quick QuoteOMCL - ) and Hims & Hers Health, Inc. ( HIMS Quick QuoteHIMS - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer ...
HIMS CEO: 'A Little Bit of Craziness' Is The Secret To Building A Global Health Platform - Hims & Hers Health ( NYSE:HIMS )
Hims & Hers Health Inc ( NYSE:HIMS ) isn't just chasing wellness trends - it's building a global health platform. At the company's third-quarter earnings call, CEO Andrew Dudum said the company's next phase will be defined by data, diagnostics, and what he calls "a little bit of craziness."
Palantir, Kimberly-Clark, Hims & Hers, Navitas And Cipher Mining: Why These 5 Stocks Are On Investors' Radars Today - Palantir Technologies ( NASDAQ:PLTR )
On Monday, major U.S. indexes showed mixed performance - the Dow Jones Industrial Average slipped nearly 0.5% to 47,336.68, while the S&P 500 edged up 0.2% to 6,851.97. The Nasdaq closed 0.46% higher at 23,834.72. These are the top stocks that gained the attention of retail traders and investors ...
Hims Hers ( HIMS ) Q3 2025 Earnings Call Transcript
Image source: The Motley Fool.Monday, Nov. 3, 2025 at 5 p.m. ETChief Executive Officer - Andrew DudumContinue reading ...
Hims & Hers Health, Inc. ( HIMS ) Q3 Earnings Match Estimates
Hims & Hers Health (HIMS) delivered earnings and revenue surprises of 0.00% and +2.62%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Hims & Hers Stock Pops After Q3 Earnings: Here's Why - Hims & Hers Health ( NYSE:HIMS )
Hims & Hers Health, Inc. ( NYSE:HIMS ) shares popped after the company released its third-quarter earnings report after Monday's closing bell. Hims said it is in active discussions to make Novo Nordisk A/S ( NYSE:NVO ) oral Wegovy and Wegovy injections available through its platform.
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Stock Market Today: S&P 500, Dow Jones Futures Rise After Stellar October Gains- Micron Tech, Palantir, Hims & Hers In Focus - SPDR S&P 500 ( ARCA:SPY )
U.S. stock futures advanced on Monday after Friday's positive moves. Futures of major benchmark indices were higher. Even as the government shutdown continued for over a month, the stocks gained in October; the S&P 500 added 1.85%, the Dow surged 1.72%, and the Nasdaq jumped 4.33%.
Hims & Hers Scales AI-Driven Personalized Health and Wellness
HIMS scales AI-driven care with new hormonal health lines, global expansion plans and a $870 million funding boost.
Is Invesco S&P MidCap 400 Pure Growth ETF ( RFG ) a Strong ETF Right Now?
Smart Beta ETF report for ...
Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings?
Hims & Hers benefits from strong platform engagement and hormonal health launches ahead of third-quarter 2025 earnings.
LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Hims & Hers Health, Inc. - Hims & Hers Health ( NYSE:HIMS )
NEW YORK, Oct. 29, 2025 ( GLOBE NEWSWIRE ) -- A securities fraud class action lawsuit against Hims & Hers Health, Inc. ( NYSE:HIMS ) is pending. The lawsuit was filed by Glancy Prongay & Murray LLP. Previous press releases stated incorrectly that Levi & Korsinsky filed the case.
Analysts Estimate Nyxoah SA ( NYXH ) to Report a Decline in Earnings: What to Look Out for
Nyxoah (NYXH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
1 Vanguard Index Fund May Beat the S&P 500 by Close to 100% in the Next Year, According to a Wall Street Analyst
The Russell 2000 index has three key things working in its favor right now.
Hims & Hers Health, Inc. ( HIMS ) Stock Dips While Market Gains: Key Facts
Hims & Hers Health, Inc. (HIMS) reached $47.12 at the closing of the latest trading day, reflecting a -2.3% change compared to its last close.
HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now?
Hims & Hers and LifeMD are reshaping virtual care, but which one leads in earnings growth and platform scale? Let's dive in.
Hims & Hers Health, Inc. ( HIMS ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Hims & Hers Health (HIMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Hims & Hers Health, Inc. ( HIMS ) Dipped More Than Broader Market Today
In the latest trading session, Hims & Hers Health, Inc. (HIMS) closed at $47.46, marking a -3.85% move from the previous day.
Hims & Hers Advances AI-Powered Personalized Digital Healthcare
HIMS accelerates AI-powered care with new tech leadership, personalized treatments and a major $870 million investment push.
HIMS Stock Declines Despite Launch of New Specialty in Women's Health
Hims & Hers debuts a new women's health specialty, targeting menopause care with personalized treatment plans.
This ACADIA Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Hims & Hers Health ( NYSE:HIMS ) , ACADIA Pharmaceuticals ( NASDAQ:ACAD )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Should Invesco Russell 2000 Dynamic Multifactor ETF ( OMFS ) Be on Your Investing Radar?
Style Box ETF report for ...
Hims & Hers Health, Inc. ( HIMS ) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Bulls And Bears: Stellantis, Papa John's, Oklo - And Trade Tensions Shake Chip Stocks Bulls And Bears: Stellantis, Papa John's, Oklo - And Trade Tensions Shake Chip Stocks - ARM Holdings ( NASDAQ:ARM ) , Amazon.com ( NASDAQ:AMZN )
Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories. Wall Street slid from record highs as President Donald Trump renewed tariff threats against China, rattling investor sentiment and triggering a pullback in ...
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
Why Hims & Hers Health Shares Are Sliding Friday - Hims & Hers Health ( NYSE:HIMS )
Shares of Hims & Hers Health Inc ( NYSE:HIMS ) are trading lower Friday morning after comments from President Donald Trump indicated that he expects the prices of popular weight-loss drugs to decrease. Here's what investors need to know. HIMS stock is trending lower. See the trading setup here.
Here's Why Hims & Hers Health, Inc. ( HIMS ) Fell More Than Broader Market
Hims & Hers Health, Inc. (HIMS) reached $59.15 at the closing of the latest trading day, reflecting a -5.75% change compared to its last close.
Eli Lilly, Novo Nordisk, Hims & Hers Health Shares Move Lower After Trump Calls Out 'Fat-Loss Drugs' - Eli Lilly ( NYSE:LLY )
Shares of Eli Lilly And Co ( NYSE:LLY ) and Novo Nordisk A/S ( NYSE:NVO ) are moving lower in Thursday's after-hours session after President Donald Trump indicated that weight-loss drugs are going to come down in price.
Hims & Hers Elevates Technology-Driven Healthcare Accessibility
HIMS boosts AI-led care with new technology chief, hormone therapies and a global push via its ZAVA acquisition.
Hims & Hers Stock's 150% Surge Is All Fundamentals-No Novo, No Problem - Hims & Hers Health ( NYSE:HIMS )
Hims & Hers Health Inc. ( NYSE:HIMS ) has become one of 2025's most surprising winners, up more than 150% year-to-date and over 200% in the past twelve months. But what's making Wall Street sit up this time is not another flashy partnership - it's a rally built from within.
HIMS, CRM, OMER, UAL, SE: 5 Trending Stocks Today - Hims & Hers Health ( NYSE:HIMS )
Major U.S. indices ended mixed on Wednesday, with the Dow Jones Industrial Average slipping 0.04% to 46,253.31. The S&P 500 added 0.4% to 6,671.06, while the Nasdaq climbed nearly 0.7% to 22,670.08. These are the top stocks that gained the attention of retail traders and investors through the day:
Why Hims & Hers Stock Blasted 16% Higher on Wednesday
Investors liked what they heard about the company's latest expansion of its business.
Investors Are Buying Hims & Hers Health Stock Following Wednesday's Platform Expansion Announcement - Hims & Hers Health ( NYSE:HIMS )
Hims & Hers Health Inc ( NYSE:HIMS ) shares are trading higher Wednesday following the company's launch of a new menopause and perimenopause care specialty on its Hers platform.
Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell?
HIMS expands into men's health and hormones, but rising costs and regulatory hurdles threaten its momentum.
Hims & Hers Health, Inc. ( HIMS ) Dips More Than Broader Market: What You Should Know
Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $53.96, signifying a -7.36% move from its prior day's close.
Hims & Hers Expands Personalized Care Access Via Telehealth Platform
HIMS expands its AI-powered telehealth platform, boosting personalized care and eyeing international growth in 2026.
Hims & Hers Health, Inc. ( HIMS ) is Attracting Investor Attention: Here is What You Should Know
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hims & Hers Expands Health Access Through Subscription Revenue Model
HIMS boosts predictable revenue and customer loyalty with a flexible, subscription-based model across key health categories.
OMCL or HIMS: Which Is the Better Value Stock Right Now?
OMCL vs. HIMS: Which Stock Is the Better Value Option?
